Prevalence of non-alcoholic esteatohepatitis in adults with metabolic syndrome in Oaxaca;Prevalencia de esteatohepatitis no alcohólica en adultos con síndrome metabólico en Oaxaca

Gaceta Medica de Mexico

Volumn 141, Issue 1, 2005, Pages 7-12

  Álvarez Martínez, Héctor Eloy ^a,b,d   Pérez Campos, Eduardo ^b,c   Leyva Bohórquez, Paulina ^b  

^a CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

^b UABJO   (Mexico)

^c Lab Patol Clin Dr E P Ortega   (Mexico)

^d NONE   (Mexico)

Author keywords

Metabolic syndrome; Non alcoholic steatohepatitis; Prevalence

Indexed keywords

ADULT; AGED; ARTICLE; DYSLIPIDEMIA; FATTY LIVER; FEMALE; HUMAN; HYPERTENSION; LIVER BIOPSY; LIVER DISEASE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HEPATITIS; HUMANS; MALE; METABOLIC SYNDROME X; MEXICO; MIDDLE AGED; PREVALENCE;

EID: 14844320039     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001;21:3-16.
2. Ramrakhiani S, Bacon BR. Hepatology in the new millennium. Med Clin North Am 2000;84:1085-105.
3. Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979;67:811-6.
4. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8.
5. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
6. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000;32:689-92.
7. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-45.
8. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology, 1994;107:1103-9.
9. Badalamenti S, Kligerman S, Molina E, Jeffers L, Reddy R, Schiff E. Clinical features commonly associated with fatty liver/non-alcoholic steatohepatitis (NASH). Hepatology 1998;28:385A.
10. Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow up study. Hepatology 1995;22:1714-9.
11. Kumar KS, Malet PF. Nonalcoholic steatohepatitis. Mayo Clin Proc 2000;75:733-9.
12. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001;21:17-26.
13. Bernal-Reyes R, Saenz-Labra A, Bernardo-Escudero R. Prevalencia de la esteatohepatitis no alcohólica (EHNA). Estudio comparativo con diabéticos. Rev Gastroenterol Mex, 2000;65:58-62.
14. Sepulveda-Flores RN, Vera-Cabrera L, Flores-Gutierrez JP, Maldonado-Garza H, Salinas-Garza R, Zorrilla-Blanco P, et al. Obesity-related non alcoholic steatohepatitis and TGF-B1 serum levels in relation to morbid obesity. Ann Hepatol 2002;1:36-9.
15. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001;121:710-23.
16. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000;342:1266-71.
17. Galambos JT, Wills CE. Relationship between 505 paired liver tests and biopsies in 242 obese patients. Gastroenterology 1978;74:1191-5.
18. Sanyal AJ. Nonalcoholic steatohepatitis. Indian J Gastroenterol 2001;Suppl 1:C64-70.
19. Isselbacher KJ. Nonalcoholic steatohepatitis: importance of liver biopsy. Update to Chapter 299: Chung RT. Podolsky DK. Cirrhosis and its complications. En: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. eds. Harrison's Principles of Internal Medicine 15th edition. New York. Mc Graw Hill; 2001. p.1754-67.
20. Graif M, Yanuka M, Baraz M, Blank A, Moshkovitz M, Kessler A, et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology In diffuse liver disease. Invest Radiol 2000;35:319-24.
21. Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis. Med Clin North Am 1996;80:1147-66.
22. Byrne T, Douglas DD, Harrison ME, Nelson L. Non-alcoholic steatohepatitis (NASH): is a liver biopsy necessary for diagnosis?. Hepatology 1997;26:388A.
23. Sherlock S. Needle biopsy of the Liver. En: Diseases of the liver and biliary system. 6a Ed. Blackwell Scientific Publications:28-35.
24. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100.
25. González ChA, Alexanderson RE, Alvarado RR, Ayub AM, Camacho AJ, Cardona MEG, et al. Consenso Mexicano de Resistencia a la Insulina y Síndrome Metabólico. Rev Mex Cardiol 1999;10:3-18.
26. Powers AC. Diabetes mellitus. En: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. ed. Harrison's Principles of Internal Medicine 15th edition. New York. Mc Graw Hill, 2001:2109-37.
27. Joint National Committee, National High Blood Pressure Education Program: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI): NIH Publication No. 98-4080. Bethesda, National Heart, Lung, and Blood Institute, National Institutes of Health, 1997.
28. González BJ, Lara GJJ, Avila RH. Concepto, definición y diagnóstico. En: Vargas AL, Bastarrachea SR, Laviada MH, González BJ y Avila RH ed. Obesidad. Consenso. McGraw-Hill Interamericana; 2002. p.1-10.
29. Hernández B, Velasco-Mondragón HE. Encuestas transversales. Salud Publica Mex 2000;42:447-55.
30. Clark JM, Diehl AM. Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. Gastroenterology 2003;124:248-50.
31. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000;136:734-8.
32. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-92.
33. Tankurt E, Biberoglu S, Ellidokuz E, Hekimsoy Z, Akpinar H, Comlekci A, et al. Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis. J Hepatol 1999;31:963.
34. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease. a feature of the metabolic syndrome. Diabetes 2001;50:1844-50.
35. Caldwell SH, Hespenheide EE, Redick JA, Iezzoni JC, Battle EH, Sheppard BL. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am J Gastroenterol 2001;96:519-25.
36. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Melchionda N. Metformin in non-alcoholic steatohepatitis. Lancet 2001;358:893-4.
37. Chalasani N, Deeg MA, Persohn S, Crabb DW. Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003;98:1849-55.
38. Angulo P, Keach JC, Batts KP y Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-62.